K180197 is an FDA 510(k) clearance for the Erchonia FX-635. Classified as Powered Light Based Laser Non-thermal Instrument With Non-heating Effect For Adjunctive Use In Pain Therapy (product code NHN), Class II - Special Controls.
Submitted by Erchonia Corporation (Melbourne, US). The FDA issued a Cleared decision on May 21, 2018 after a review of 117 days - within the typical 510(k) review window.
This device falls under the Physical Medicine FDA review panel, regulated under 21 CFR 890.5500 - the FDA physical medicine device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Physical Medicine review framework, consistent with the majority of Class II 510(k) submissions.
View all Erchonia Corporation devices
NCT02538523
Completed
Interventional
Industry-sponsored
A Study to Evaluate the Effect of Low Level Laser Light on Low Back Pain
A Double-Blind, Placebo-Controlled Randomized Evaluation of the Effect of the Erchonia FX-635 on Low Back Pain
| Condition studied |
Low Back Pain |
| Study design |
Parallel |
| Eligibility |
All sexes
· 18 Years+
|
| Principal investigator |
Trevor Berry, DC |
| Sponsor |
Erchonia Corporation
(industry)
|
Started 2016-04-08
→
Primary completion 2017-10-07
→
Completed 2017-12-10
Primary outcome
Percentage of Participants Whose Change in Pain Rating on the Visual Analog Scale (VAS) Met the Individual Subject Success Criteria
Secondary outcome
Change in Total Score on the Oswestry Disability Index (ODI)
View full study on ClinicalTrials.gov